Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

PMI vs AMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: PMI 0 – 6 AMD Matrix Metrics: PMI 2 – 8 AMD

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Picard Medical, Inc. (PMI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas AMD carries 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin).

  • Composite vs. Pillar Nuance: While PMI currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. AMD 46.7/100 HOLD), AMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (17.8% vs. -248.1% operating margin) and revenue trajectory (+44.7% vs. +38.6% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PMI vs AMD
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
TTM Revenue $6.3M
Forward P/E N/M
Beta / 30D Vol 54.06β · 134% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.1 · SMA20: $7.55 · SMA50: $7.62
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$489.19
-7.72% 1D
Market Cap $877.4B
TTM Revenue $45.4B
Forward P/E 27.3x
Beta / 30D Vol 3.61β · 120% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 18.0 Fund 38.0 Flow 58.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.2 · SMA20: $513.70 · SMA50: $554.93

6-Pillar Scorecard Institutional Category Breakdown (PMI 0 – 6 AMD)

Columns: Metric · PMI · AMD
1. Valuation Multiples AMD
Forward P/E N/M 27.3x
Trailing P/E 2.9x 113.3x
PEG Ratio N/M 0.45x
EV / Revenue 3.2x 19.3x
2. Growth & Scale AMD
Revenue Growth (YoY) +38.6% +44.7%
Earnings Growth (YoY) +0.0% +93.8%
TTM Revenue (USD) $6.3M $45.4B
Market Cap $17.1M $877.4B
3. Profitability & Quality AMD
Gross Margin 18.6% 56.0%
Operating Margin -248.1% 17.8%
Net Profit Margin 0.0% 16.8%
Return on Equity (ROE) 0.0% 12.0%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) -$17M $7.06B
Cash Flow Margin N/A 15.5%
Net Cash / Leverage $3.2M Net Debt $1.51B Net Debt (0.13x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 128.2% (17th %ile)
Put/Call OI Skew N/A 1.08x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity N/A 38.2% of Rev ($17.4B)
90D R&D Disclosures 0 papers 7 papers
Competitive Moat Cyclical / Execution-Driven Positioning Concentrated Oligopoly Moat
Supply-Chain Role Medical Devices Operator AI Accelerator & Server Chiplet Designer

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PMI (2) vs AMD (8)
Institutional Metric PMI AMD Criterion Row Edge
Market Capitalization
Scale
$17.1M $877.4B Larger Scale AMD
Trailing P/E Ratio
Valuation
2.9x 113.3x Lower Multiple PMI
Forward P/E Ratio
Valuation
N/M 27.3x Lower Multiple AMD
Revenue Growth (YoY)
Growth
+38.6% +44.7% Higher Growth AMD
Operating Margin (TTM)
Profitability
-248.1% 17.8% Higher Margin AMD
Net Profit Margin
Profitability
0.0% 16.8% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
0.0% 12.0% Higher ROE AMD
52-Week Range Position
Momentum
34% ($0–$18) 64% ($188–$659) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
54.06β · 134% Vol 3.61β · 120% Vol Lower Realized Risk AMD
Unified Institutional Score
Composite Signal
48.4 / 100 (HOLD) 46.7 / 100 (HOLD) Higher Composite PMI
Trailing 12M Revenue (USD)
Operating Scale
$6.3M $45.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
18.6% 56.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev 0.45x PEG · 19.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$17M ($3.2M Net Debt) $7.06B ($1.51B Net Debt (0.13x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +23.09 pp
PMI: -34.58% · AMD: -11.49%
3M Horizon PMI +92.89 pp
PMI: +96.26% · AMD: +3.37%
6M Horizon PMI +3430.21 pp
PMI: +3439.33% · AMD: +9.12%
1Y Horizon PMI +35.61 pp
PMI: +148.03% · AMD: +112.42%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PMI Revenue AMD Revenue PMI Op. Margin AMD Op. Margin Margin Leader
FY2018 N/A $6.47B N/A 7.0% AMD
FY2019 N/A $6.73B N/A 9.4% AMD
FY2020 N/A $9.76B N/A 14.0% AMD
FY2021 N/A $16.4B N/A 22.2% AMD
FY2022 N/A $23.6B N/A 5.4% AMD
FY2023 N/A $22.7B N/A 1.8% AMD
FY2024 $0M $25.8B -312.3% 7.4% AMD
FY2025 $0M $34.6B -268.4% 10.7% AMD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PMI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PMI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AMD CONSOLIDATION
106d in phase · OBV NEUTRAL
Current IV 128.2%
IV Percentile 17th %ile
Put/Call OI Skew 1.08x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $450.00
Call Wall Magnet $500.00
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Put Floor: $450.00 (-8.0%) Spot: $489.19 Call Magnet: $500.00 (+2.2%)
  • Extended consolidation (106 days)
  • IV expanding (+13.5%) but put wall rising - pre-earnings positioning (neutral)
  • Put wall rising (+$50) - support strengthening
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $504.28 · IV 73.5%

AMD Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($50,428)

Compare $50,428 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 73.5% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $510 / $580 Bull Call Spread

Buy 1x $510C · Sell 1x $580C · 31d

Net Entry $2,436 Debit
T+5d @ +5% Move +$583 (+24%)
Max Risk / Buffer $2,436 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $440 / $410 Bull Put Spread

Sell 1x $440P · Buy 1x $410P · 31d

Net Entry $731 Credit
Max Credit / Yield +$731 (+32.2% RoM)
Max Risk / Buffer -14.2% Cushion ($2,269 Mgn)
5d Edge & Liquidity 76% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $450P / $520-$590C Seagull

Sell 1x $450P · Buy 1x $520/$590C · 31d

Net Entry $52 Debit
T+5d @ +5% Move +$1,463 (+21.3% RoM)
Max Risk / Buffer -10.8% Put Cushion ($6,861 Mgn)
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PMI Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $17.1M market capitalization and -248.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models

Investor FAQ PMI vs AMD Key Questions & Quantitative Answers

As of Nov 19, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over Picard Medical, Inc. (PMI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PMI carries a Unified Composite Score of 48.4/100 (HOLD) at $6.30 (N/M Forward P/E, -248.1% operating margin), whereas AMD carries 46.7/100 (HOLD) at $489.19 (27.3x Forward P/E, 17.8% operating margin). Composite vs. Pillar Nuance: While PMI currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. AMD 46.7/100 HOLD), AMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (17.8% vs. -248.1% operating margin) and revenue trajectory (+44.7% vs. +38.6% YoY).

AMD leads the Growth & Scale pillar: PMI posts +38.6% YoY revenue growth and +0.0% YoY earnings growth on $6.3M TTM revenue (18.6% gross margin, -248.1% operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), PMI cumulative revenue shifted N/A while AMD shifted +435.4%. In operating R&D and SG&A reinvestment, PMI deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.

AMD screens cheaper on headline valuation multiples. PMI trades at N/M Forward P/E, 2.9x Trailing P/E, N/M PEG, and 3.2x EV/Revenue (unreported FCF margin), whereas AMD trades at 27.3x Forward P/E, 113.3x Trailing P/E, 0.45x PEG, and 19.3x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMI (0.0% ROE) versus AMD (12.0% ROE) capital efficiency.

In options market volatility and institutional positioning, PMI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (54.06β · 134% Vol realized risk). By comparison, AMD carries 128.2% implied volatility (17th %ile, Compressed (<25th %ile)), a 1.08x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (3.61β · 120% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.